Materiały źródłowe

• #1 Overview of paraneoplastic syndromes of the nervous system – UpToDate

  https://www.uptodate.com/contents/overview-of-paraneoplastic-syndromes-of-the-nervous-system

  Paraneoplastic neurologic syndromes are a heterogeneous group of neurologic disorders caused by mechanisms other than metastases, metabolic and nutritional deficits, infections, coagulopathy, or side effects of cancer treatment. These syndromes may affect any part of the nervous system, from cerebral cortex to neuromuscular junction and muscle, either damaging one area or multiple areas. […] This topic provides an overview of the pathogenesis, diagnosis, and treatment of paraneoplastic neurologic disorders. Individual syndromes are discussed separately. […] DIAGNOSTIC EVALUATION […] Diagnostic criteria […] Antibody screening […] Testing methods […] Interpretation […] Other diagnostic tests […] Neuroimaging […] Lumbar puncture […] Electrophysiology […] Search for occult malignancy.

• #2 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that are not caused by the tumor and its metastasis, or by infection, ischemia or metabolic disruptions. […] In most patients, the neurological disorder develops before the cancer becomes clinically overt and the patient is referred to neurologist who has the charge of identifying a neurological disorder as paraneoplastic. […] The presence or the absence of paraneoplastic antibodies and the type of antibodies define different subtypes of PNS. […] Recently, an international panel of neurologists reviewed the existing criteria for diagnosis of PNS and recommended new diagnosis criteria for PNS. […] Each level can be reached combining a set of criteria, which are based on the presence or absence of cancer, and the definitions of „classical” syndrome and „well characterized” onconeural antibody.

• #3 Paraneoplastic syndromes of the nervous system – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/paraneoplastic-syndromes/symptoms-causes/syc-20355687

  Paraneoplastic syndromes of the nervous system are a group of rare conditions that develop in some people who have cancer. […] Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] Symptoms of paraneoplastic syndromes of the nervous system can develop relatively quickly, often over days to weeks. […] But if you have any symptoms suggesting a paraneoplastic syndrome, see your healthcare professional as soon as possible. Early diagnosis and appropriate care are important for treating the cancer and preventing further damage of the nervous system. […] Paraneoplastic syndromes of the nervous system are not caused by cancer cells directly or by the cancer spreading, known as metastasis.

• #4 Paraneoplastic syndromes of the nervous system | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/paraneoplastic-syndromes-nervous-system

  Paraneoplastic syndromes of the nervous system are a group of rare conditions that develop in some people who have cancer. […] Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] Symptoms of paraneoplastic syndromes of the nervous system can develop relatively quickly, often over days to weeks. […] But if you have any symptoms suggesting a paraneoplastic syndrome, see your healthcare professional as soon as possible. Early diagnosis and appropriate care are important for treating the cancer and preventing further damage of the nervous system. […] To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture.

• #5 Paraneoplastic syndromes of the nervous system – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/paraneoplastic-syndromes/symptoms-causes/syc-20355687

  Researchers believe that paraneoplastic syndromes of the nervous system are caused by cancer-fighting abilities of the immune system. […] Any cancer may be associated with a paraneoplastic syndrome of the nervous system. However, it occurs more often in people with cancers of the lung, ovary, breast, testis or lymphatic system.

• #6 Paraneoplastic neurological syndromes: a practical approach to diagnosis and management | Practical Neurology

  https://pn.bmj.com/content/22/1/19

  Paraneoplastic neurological syndromes (PNS) are the immune-mediated effects of a remote cancer and are characterised by an autoantibody response against antigens expressed by the tumour. […] The clinical syndrome helps to direct the search for a specific set of tumours. […] Overall, the clinical, serological and oncological features in an individual patient help to determine the clinical relevance of the syndrome and hence guide its management. […] Distinctive clinical and serological features typically direct the search for a tumour, which is subsequently detected in around 65% of cases. […] A key feature of PNS is that the cancer triggers the immune response, and so it should express the autoantigen to which the immune response (including an autoantibody) is directed: this ensures a direct biological link between the cancer and PNS.

• #7 Paraneoplastic syndromes of the nervous system // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/paraneoplastic-syndromes-of-the-nervous-system

  Paraneoplastic syndromes of the nervous system are a group of rare conditions that develop in some people who have cancer. […] Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] Symptoms of paraneoplastic syndromes of the nervous system can develop relatively quickly, often over days to weeks. […] But if you have any symptoms suggesting a paraneoplastic syndrome, see your healthcare professional as soon as possible. Early diagnosis and appropriate care are important for treating the cancer and preventing further damage of the nervous system. […] To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture.

• #8 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Paraneoplastic neurological disorders (PNDs) are an extensive group of syndromes that can affect any part of the nervous system by mechanisms that are mostly immune mediated. […] In 60% of patients with PND, symptoms develop before the presence of a tumor is known; the majority of these patients are seen by neurologists, who should be aware that prompt diagnosis and treatment of the tumor along with immunotherapy may stabilize or improve the PND. […] The diagnosis of PND has been facilitated by serological tests that are based on the detection of antineuronal antibodies in the patients serum or cerebrospinal fluid (CSF), but in at least 40% of patients, no antibodies are detected, and in some instances, the antibodies can be detected in patients who have cancer but not PND. […] The diagnosis of PNDs is usually based on (1) the recognition of the neurological syndrome, (2) the demonstration of the associated cancer, and (3) the detection of serum and CSF paraneoplastic antibodies.

• #9 Chapter 79: Neurologic Paraneoplastic Syndromes | Harrison’s Manual of Medicine

  https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623219/all/Chapter_79:_Neurologic_Paraneoplastic_Syndromes

  Paraneoplastic neurologic disorders (PNDs) are cancer-related syndromes that can affect any part of the nervous system; caused by mechanisms other than metastasis or by complications of cancer such as coagulopathy, stroke, metabolic and nutritional conditions, infections, and side effects of cancer therapy. […] In 60% of pts the neurologic symptoms precede cancer diagnosis. […] PNDs occur in 0.51% of all cancer pts, but they occur in 23% of pts with neuroblastoma or small cell lung cancer (SCLC), and in 30-50% of pts with thymoma or sclerotic myeloma.

• #10 Paraneoplastic syndromes of the nervous system | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/paraneoplastic-syndromes-nervous-system

  Paraneoplastic syndromes of the nervous system are a group of rare conditions that develop in some people who have cancer. […] Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] Symptoms of paraneoplastic syndromes of the nervous system can develop relatively quickly, often over days to weeks. […] But if you have any symptoms suggesting a paraneoplastic syndrome, see your healthcare professional as soon as possible. Early diagnosis and appropriate care are important for treating the cancer and preventing further damage of the nervous system. […] To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture.

• #11 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  Paraneoplastic neurological syndromes (PNS) can be defined as remote effects of cancer that are not caused by the tumor and its metastasis, or by infection, ischemia or metabolic disruptions. […] In most patients, the neurological disorder develops before the cancer becomes clinically overt and the patient is referred to neurologist who has the charge of identifying a neurological disorder as paraneoplastic. […] The presence or the absence of paraneoplastic antibodies and the type of antibodies define different subtypes of PNS. […] Recently, an international panel of neurologists reviewed the existing criteria for diagnosis of PNS and recommended new diagnosis criteria for PNS. […] Each level can be reached combining a set of criteria, which are based on the presence or absence of cancer, and the definitions of „classical” syndrome and „well characterized” onconeural antibody.

• #12 Paraneoplastic Syndromes Workup: Approach Considerations, Blood Studies, Imaging Studies

  https://emedicine.medscape.com/article/280744-workup

  The update includes a new clinical scoring system for diagnosis of paraneoplastic neurologic syndrome, the Paraneoplastic (PNS)-Care Score. The PNS-Care Score assesses three factors: Phenotype classification, Associated antibody level, Presence of cancer. […] Many patients with paraneoplastic disorders may have autoantibodies against several tissues of the body. Demonstration of these autoantibodies is very important to confirm the diagnosis of a paraneoplastic syndrome and distinguish it from nonneoplastic forms. […] Any possible imaging study may be useful to detect the primary tumor in patients with paraneoplastic disorders.

• #13 Paraneoplastic Syndromes Workup: Approach Considerations, Blood Studies, Imaging Studies

  https://emedicine.medscape.com/article/280744-workup

  Patients with a suspected paraneoplastic disorder should undergo a complete panel of laboratory studies of blood, urine, and cerebrospinal fluid (CSF). Selection of further studies is dictated by the clinical presentation. […] Assays for autoantibodies may confirm the paraneoplastic origin of a patients condition. Most autoantibodies involved in paraneoplastic syndromes are directed against nervous system structures. […] In 2021, an international panel of experts published an update to the 2004 criteria for the diagnosis of paraneoplastic neurologic syndromes. Under the updated criteria, neurologic phenotypes are classified as high risk or intermediate risk for cancer, and associated antibodies are classified as high risk (cancer in 70% of patients with the antibody), intermediate risk (cancer in 30%-70%), and low risk (cancer in 30%).

• #14 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  PNS is „definite” when: a classical neurological syndrome is observed (encephalomyelitis, limbic encephalitis, subacute cerebellar degeneration, sensory neuronopathy, opsoclonus-myoclonus, chronic gastrointestinal pseudoobstruction, Lambert-Eaton myasthenic syndrome or dermatomyositis) and cancer develops within five years of the diagnosis of the neurological disorder. […] PNS is „possible” when: a patient with classical neurological syndrome has no onconeural antibodies and no cancer, but has a high risk to have underlying tumor. […] It has been shown that several PNS are associated with onconeural antibodies. […] Detection of an onconeural antibody in a patient suspected to have a PNS is, at present, the most valuable diagnostic test. […] If paraneoplastic antibodies are present, they direct the tumor search to specific organs.

• #15 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  PNS is „definite” when: a classical neurological syndrome is observed (encephalomyelitis, limbic encephalitis, subacute cerebellar degeneration, sensory neuronopathy, opsoclonus-myoclonus, chronic gastrointestinal pseudoobstruction, Lambert-Eaton myasthenic syndrome or dermatomyositis) and cancer develops within five years of the diagnosis of the neurological disorder. […] PNS is „possible” when: a patient with classical neurological syndrome has no onconeural antibodies and no cancer, but has a high risk to have underlying tumor. […] It has been shown that several PNS are associated with onconeural antibodies. […] Detection of an onconeural antibody in a patient suspected to have a PNS is, at present, the most valuable diagnostic test. […] If paraneoplastic antibodies are present, they direct the tumor search to specific organs.

• #16 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  If no malignancy is revealed during initial workup, surgical exploration and removal of pelvic organs may be warranted, particularly in postmenopausal women. […] The different subtypes of PNS are defined by the presence or the absence of paraneoplastic antibodies and the type of antibodies. […] Management and treatment should be tailored to each subtype. […] An early diagnosis of a neurological syndrome as PNS is thus crucial for the management of patients.

• #17 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  If no malignancy is revealed during initial workup, surgical exploration and removal of pelvic organs may be warranted, particularly in postmenopausal women. […] The different subtypes of PNS are defined by the presence or the absence of paraneoplastic antibodies and the type of antibodies. […] Management and treatment should be tailored to each subtype. […] An early diagnosis of a neurological syndrome as PNS is thus crucial for the management of patients.

• #18 What Is Paraneoplastic Syndrome? Understanding This Rare Condition

  https://drchandrilchugh.com/paraneoplastic-syndromes/what-is-paraneoplastic-syndrome-understanding-this-rare-condition/

  Paraneoplastic syndromes are uncommon disorders. They happen when the bodys immune system reacts to a cancer tumor. Instead of attacking the tumor, the immune system fights normal cells in the nervous system. This battle causes various symptoms. […] Diagnosing paraneoplastic syndromes is tricky. This is because their symptoms look like those of many other illnesses, including the cancer itself. Getting checked by a doctor quickly, and doing the right tests is crucial. This helps find the cancer that might be causing the syndrome. It also identifies the specific type of paraneoplastic syndrome. […] To diagnose paraneoplastic syndrome, doctors use various lab tests. These include blood tests and spinal taps. The goal is to find specific antibodies linked to the syndrome. If these antibodies are found in the blood and cerebrospinal fluid (CSF), it strongly suggests paraneoplastic syndrome as the cause of the symptoms.

• #19 Paraneoplastic syndromes of the nervous system

  https://www.mymlc.com/health-information/diseases-and-conditions/p/paraneoplastic-syndromes-of-the-nervous-system/?section=Symptoms

  Paraneoplastic syndromes of the nervous system are a group of uncommon disorders that develop in some people who have cancer. Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] To diagnose paraneoplastic syndrome of the nervous system, your doctor will need to conduct a physical exam and order blood tests. He or she may also need to request a spinal tap or imaging tests. […] Because paraneoplastic syndromes of the nervous system are associated with cancer, your doctor may also perform certain cancer screening tests based on your age. […] Your doctor or a neurologist will conduct a general physical, as well as a neurological exam. […] Laboratory tests will likely include: Blood tests. You may have blood drawn for a number of laboratory tests, including tests to identify antibodies commonly associated with paraneoplastic syndromes.

• #20 What is the Diagnosis of Paraneoplastic Syndrome? | OnlyMyHealth

  https://www.onlymyhealth.com/what-diagnosis-paraneoplastic-syndrome-12977605518

  Tests will be conducted by a doctor or a neurologist and things like reflexes, muscle strength, muscle tone, sense of touch, vision and hearing, etc. will be tested. […] To diagnose the problem a general and neurological examination will be conducted by a doctor or neurologist. Tests will be conducted to check the following: […] Reflexes […] Muscle strength […] Muscle tone […] Sense of touch […] Vision and hearing […] Coordination […] Balance […] Mental status […] Mood.

• #21 Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome | Mahta | World Journal of Oncology

  https://wjon.org/index.php/wjon/article/view/571/407

  The first step in diagnosis of PNS is to rule out other etiologies including infections, connective tissue disorders, metabolic causes or even drug side effects. If the initial work up is inconclusive, the next step would be looking for malignancy based on history, physical exam and paraclinic findings. If there is an evidence of cancer and the neurological syndrome is typical, the diagnosis is highly suggestive of PNS and further testing for onconeuronal antibodies can be helpful but is not necessary. […] Chemotherapy plus an immunosuppressive therapy and/or plasmapheresis should be initiated as soon as the diagnosis is established, however; the neurologic symptoms may or may not improve after treatment.

• #22 Paraneoplastic syndromes of the nervous system – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/paraneoplastic-syndromes/diagnosis-treatment/drc-20355691

  To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture. […] Because paraneoplastic syndromes of the nervous system are associated with cancer, you may need certain cancer screening tests based on your age. […] Your healthcare professional or a neurologist conducts a general physical and a neurological exam. […] Laboratory tests may include: […] You may have blood drawn for a number of tests, including tests to pinpoint antibodies commonly associated with paraneoplastic syndromes of the nervous system. […] During a spinal tap, a sample of cerebrospinal fluid (CSF) is taken. […] Sometimes paraneoplastic antibodies are found in CSF but they can’t be seen in your blood. If these antibodies are found in both your CSF and blood, it provides strong evidence that a paraneoplastic syndrome is causing the symptoms.

• #23 Paraneoplastic syndromes of the nervous system | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/paraneoplastic-syndromes-nervous-system

  Because paraneoplastic syndromes of the nervous system are associated with cancer, you may need certain cancer screening tests based on your age. […] Your healthcare professional or a neurologist conducts a general physical and a neurological exam. […] Laboratory tests may include: Blood tests. You may have blood drawn for a number of tests, including tests to pinpoint antibodies commonly associated with paraneoplastic syndromes of the nervous system. […] During a spinal tap, a sample of cerebrospinal fluid (CSF) is taken. […] Imaging tests are used to find a tumor or other causes of your symptoms. […] If tests don’t find a cancerous tumor or another cause of your symptoms, you might have a tumor that is still too small to find. […] Treatment of paraneoplastic syndromes of the nervous system involves treating the cancer. […] Sometimes treatment also involves suppressing the immune response that’s causing your symptoms. […] If you have a paraneoplastic neurologic syndrome, it’s generally recommended that you don’t use certain cancer medicines called immune checkpoint inhibitors.

• #24 Paraneoplastic neurological syndromes | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-2-22

  PNS is „definite” when: a classical neurological syndrome is observed (encephalomyelitis, limbic encephalitis, subacute cerebellar degeneration, sensory neuronopathy, opsoclonus-myoclonus, chronic gastrointestinal pseudoobstruction, Lambert-Eaton myasthenic syndrome or dermatomyositis) and cancer develops within five years of the diagnosis of the neurological disorder. […] PNS is „possible” when: a patient with classical neurological syndrome has no onconeural antibodies and no cancer, but has a high risk to have underlying tumor. […] It has been shown that several PNS are associated with onconeural antibodies. […] Detection of an onconeural antibody in a patient suspected to have a PNS is, at present, the most valuable diagnostic test. […] If paraneoplastic antibodies are present, they direct the tumor search to specific organs.

• #25 Paraneoplastic syndromes of the nervous system – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/paraneoplastic-syndromes/diagnosis-treatment/drc-20355691

  To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture. […] Because paraneoplastic syndromes of the nervous system are associated with cancer, you may need certain cancer screening tests based on your age. […] Your healthcare professional or a neurologist conducts a general physical and a neurological exam. […] Laboratory tests may include: […] You may have blood drawn for a number of tests, including tests to pinpoint antibodies commonly associated with paraneoplastic syndromes of the nervous system. […] During a spinal tap, a sample of cerebrospinal fluid (CSF) is taken. […] Sometimes paraneoplastic antibodies are found in CSF but they can’t be seen in your blood. If these antibodies are found in both your CSF and blood, it provides strong evidence that a paraneoplastic syndrome is causing the symptoms.

• #26 Paraneoplastic Neurological Disorders | PM&R KnowledgeNow

  https://now.aapmr.org/neuromuscular-manifestations-of-neoplasms-and-paraneoplastic-syndromes/

  Paraneoplastic neurological syndromes (PNS) are a group of neurological disorders resulting from an immune response triggered by an underlying tumor that affects the central and/or peripheral nervous systems, directed originally against the tumor itself. […] Patients with suspected PNS should obtain both serum and CSF antibody screening. Antibodies against intracellular antigens are almost always detectable in serum. Antibodies against cell-surface or synaptic proteins may be absent in serum testing and are typically found in higher titers in CSF than serum. […] Early diagnosis is critical as delays in care can lead to permanent neurological deficits, although literature evaluating early prognostic factors is limited. […] PNS is difficult to diagnose but early diagnosis and initiation of treatment is critical to prevent permanent neurological deficits. Symptoms of PNS may include ataxia, encephalitis, peripheral neuropathy, memory problems, seizures, sensory motor neuropathies, anorexia, rapid weight loss and fatigue. […] The different subtypes of PNS are defined by the presence or the absence of paraneoplastic antibodies and the type of antibodies. Management and treatment should be tailored to each subtype. […] Coordination between the physiatrist, therapist, oncologist, and neurologist are paramount.

• #27 Paraneoplastic syndromes of the nervous system // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/paraneoplastic-syndromes-of-the-nervous-system

  Because paraneoplastic syndromes of the nervous system are associated with cancer, you may need certain cancer screening tests based on your age. […] Your healthcare professional or a neurologist conducts a general physical and a neurological exam. […] Laboratory tests may include: […] During a spinal tap, a sample of cerebrospinal fluid (CSF) is taken. […] Imaging tests are used to find a tumor or other causes of your symptoms. […] If tests don’t find a cancerous tumor or another cause of your symptoms, you might have a tumor that is still too small to find. […] Treatment of paraneoplastic syndromes of the nervous system involves treating the cancer. […] Sometimes treatment also involves suppressing the immune response that’s causing your symptoms. […] In addition to cancer treatments, such as chemotherapy, your healthcare professional may prescribe one or more medicines.

• #28 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Most PNDs develop and progress rapidly until stabilization in a few weeks or months, causing severe disability. […] All patients with PNDs of the CNS and some peripheral nerve syndromes (e.g., plexopathies) should undergo neuroimaging evaluation of the involved area. […] In most PNDs of the CNS, the function of the blood-brain barrier is preserved, and therefore the affected brain regions are rarely enhanced with contrast material. […] Detection of CSF antibodies is a strong indicator that the associated neurological syndrome is paraneoplastic. […] Close oncological surveillance should be undertaken in patients with classical PNDs with or without paraneoplastic antibodies and in patients with nonclassical PND and paraneoplastic antibodies. […] Paraneoplastic antibodies are antibodies whose presence serves as a marker of the paraneoplastic origin of a neurological syndrome. […] Detection of any of these antibodies strongly supports the diagnosis of PND even if no tumor is found at initial evaluation.

• #29 Paraneoplastic syndromes of the nervous system – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/paraneoplastic-syndromes/diagnosis-treatment/drc-20355691

  Imaging tests are used to find a tumor or other causes of your symptoms. […] If tests don’t find a cancerous tumor or another cause of your symptoms, you might have a tumor that is still too small to find. […] Your healthcare professional likely will recommend that you have follow-up tests every 3 to 6 months until a cause is found.

• #30 Paraneoplastic Neurological Syndromes: Diagnosis and Treatment Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/paraneoplastic-neurological-syndromes-diagnosis-and-treatment-strategies/

  Paraneoplastic neurological syndromes (PNS) are rare in neurology, but they pack a punch with diverse clinical presentations and dysautonomia linked to the tumor. […] Understanding PNS in neurology is crucial for early detection and treatment, which can improve outcomes for patients with brain conditions through immunotherapy. […] Identifying paraneoplastic neurological syndromes (PNS) early in neurology patients with brain tumours can significantly improve patient outcomes. […] Use comprehensive diagnostic guidelines and clues, including antibody testing, to accurately identify PNS and differentiate them from other neurological disorders in neurology, considering autoantibodies and syndrome involvement. […] Diagnosing PNS involves several steps: Identifying underlying cancer through imaging studies. Detecting specific antibodies in blood or spinal fluid. Conducting nerve conduction studies and MRI scans.

• #31 Imaging Review of Paraneoplastic Neurologic Syndromes | American Journal of Neuroradiology

  http://www.ajnr.org/content/early/2020/10/22/ajnr.A6815

  As with limbic encephalitis, brain MR imaging, paraneoplastic antibody testing, and oncologic work-up are key to diagnosis. […] The primary differential to exclude in limbic encephalitis with mesial temporal lobe involvement is herpes simplex viral encephalitis. […] Diagnostic criteria for limbic encephalitis include subacute symptom onset over less than 3 months, limbic system abnormalities on brain MR imaging, EEG showing epileptic or slow-wave activity in the temporal lobes or CSF pleocytosis, and reasonable exclusion of other etiologies. […] In addition to brain MR imaging and usual paraneoplastic antibody screening, screening for the newly discovered KLHL11 autoantibodies should be done when diagnosing these patients. […] Diagnosis requires a thorough neurologic work-up, and ophthalmologic consultation is helpful if ophthalmoplegia is identified.

• #32 Paraneoplastic Neurological Syndromes: Diagnosis and Treatment Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/paraneoplastic-neurological-syndromes-diagnosis-and-treatment-strategies/

  Treatment focuses on managing both the cancer and paraneoplastic neurological symptoms in patients with a tumour. […] Early recognition of PNS is essential for effective treatment. Identifying these syndromes quickly allows doctors to start appropriate therapies sooner, according to a pubmed article found on google. […] Paraneoplastic neurological syndromes (PNS) can be challenging to diagnose. Early symptoms often appear before any detectable cancer. This makes early diagnosis crucial. Diagnostic criteria include a combination of clinical assessment and laboratory findings, as noted in the article on PubMed. […] Onconeural antibodies play a significant role in diagnosing PNS. These antibodies target proteins in neurons and are found in the blood of patients with PNS, as noted in a PubMed article found via Google. Seropositive cases indicate the presence of these antibodies, which helps confirm the diagnosis, as reported in the article on PubMed and Google. […] Detecting an underlying malignancy is crucial in managing PNS. Onconeural antibodies guide doctors to look for specific cancers, such as lung or breast cancer, pubmed, google. Early detection of cancer improves treatment outcomes significantly.

• #33 Paraneoplastic Neurological Syndromes: Diagnosis and Treatment Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/paraneoplastic-neurological-syndromes-diagnosis-and-treatment-strategies/

  Treatment focuses on managing both the cancer and paraneoplastic neurological symptoms in patients with a tumour. […] Early recognition of PNS is essential for effective treatment. Identifying these syndromes quickly allows doctors to start appropriate therapies sooner, according to a pubmed article found on google. […] Paraneoplastic neurological syndromes (PNS) can be challenging to diagnose. Early symptoms often appear before any detectable cancer. This makes early diagnosis crucial. Diagnostic criteria include a combination of clinical assessment and laboratory findings, as noted in the article on PubMed. […] Onconeural antibodies play a significant role in diagnosing PNS. These antibodies target proteins in neurons and are found in the blood of patients with PNS, as noted in a PubMed article found via Google. Seropositive cases indicate the presence of these antibodies, which helps confirm the diagnosis, as reported in the article on PubMed and Google. […] Detecting an underlying malignancy is crucial in managing PNS. Onconeural antibodies guide doctors to look for specific cancers, such as lung or breast cancer, pubmed, google. Early detection of cancer improves treatment outcomes significantly.

• #34 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Most PNDs develop and progress rapidly until stabilization in a few weeks or months, causing severe disability. […] All patients with PNDs of the CNS and some peripheral nerve syndromes (e.g., plexopathies) should undergo neuroimaging evaluation of the involved area. […] In most PNDs of the CNS, the function of the blood-brain barrier is preserved, and therefore the affected brain regions are rarely enhanced with contrast material. […] Detection of CSF antibodies is a strong indicator that the associated neurological syndrome is paraneoplastic. […] Close oncological surveillance should be undertaken in patients with classical PNDs with or without paraneoplastic antibodies and in patients with nonclassical PND and paraneoplastic antibodies. […] Paraneoplastic antibodies are antibodies whose presence serves as a marker of the paraneoplastic origin of a neurological syndrome. […] Detection of any of these antibodies strongly supports the diagnosis of PND even if no tumor is found at initial evaluation.

• #35 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis

  A systematic review of current guidelines suggests that PNS-related antibody testing is helpful for defining the probability of whether a neurological disorder has a paraneoplastic origin but should not be used to screen for malignancy. […] The presence of an antibody is associated with certain PNSs and malignancies. […] To confirm the presence of an underlying malignancy, positive antibody test results must be followed with imaging or other laboratory tests.

• #36 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis?p=r

  Laboratory tests can identify specific autoantibodies that indicate possible PNSs and can guide the search for an underlying malignancy. However, a single antibody can be associated with multiple syndromes and cancer types, and a single syndrome or cancer type can be associated with multiple antibodies. […] This Clinical Focus discusses the role of autoantibody testing in the diagnosis of PNSs and associated cancer and tumor types. […] Individuals suitable for testing include individuals who have signs and symptoms consistent with a PNS, individuals who have a PNS with an unidentified underlying malignancy, and individuals with rapidly progressive neurological symptoms of unknown etiology. […] If a specific syndrome is suspected based on the clinical presentation, individual antibody tests may help identify the presence of an underlying malignancy.

• #37 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis?p=r

  Laboratory tests can identify specific autoantibodies that indicate possible PNSs and can guide the search for an underlying malignancy. However, a single antibody can be associated with multiple syndromes and cancer types, and a single syndrome or cancer type can be associated with multiple antibodies. […] This Clinical Focus discusses the role of autoantibody testing in the diagnosis of PNSs and associated cancer and tumor types. […] Individuals suitable for testing include individuals who have signs and symptoms consistent with a PNS, individuals who have a PNS with an unidentified underlying malignancy, and individuals with rapidly progressive neurological symptoms of unknown etiology. […] If a specific syndrome is suspected based on the clinical presentation, individual antibody tests may help identify the presence of an underlying malignancy.

• #38 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis?p=r

  Laboratory tests can identify specific autoantibodies that indicate possible PNSs and can guide the search for an underlying malignancy. However, a single antibody can be associated with multiple syndromes and cancer types, and a single syndrome or cancer type can be associated with multiple antibodies. […] This Clinical Focus discusses the role of autoantibody testing in the diagnosis of PNSs and associated cancer and tumor types. […] Individuals suitable for testing include individuals who have signs and symptoms consistent with a PNS, individuals who have a PNS with an unidentified underlying malignancy, and individuals with rapidly progressive neurological symptoms of unknown etiology. […] If a specific syndrome is suspected based on the clinical presentation, individual antibody tests may help identify the presence of an underlying malignancy.

• #39 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis?p=r

  A systematic review of current guidelines suggests that PNS-related antibody testing is helpful for defining the probability of whether a neurological disorder has a paraneoplastic origin but should not be used to screen for malignancy. […] Detection of antineuronal autoantibodies aids the diagnosis of autoimmune paraneoplastic syndromes, encephalopathies, and other autoimmune neurological conditions. Identification of specific antineuronal autoantibodies may also help in the diagnostic workup for occult malignancies.

• #40 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis

  A systematic review of current guidelines suggests that PNS-related antibody testing is helpful for defining the probability of whether a neurological disorder has a paraneoplastic origin but should not be used to screen for malignancy. […] The presence of an antibody is associated with certain PNSs and malignancies. […] To confirm the presence of an underlying malignancy, positive antibody test results must be followed with imaging or other laboratory tests.

• #41 Paraneoplastic Reflexive Panel, Serum and CSF | Test Fact Sheet

  https://arupconsult.com/ati/paraneoplastic-reflexive-panel

  Paraneoplastic neurologic syndromes are rare disorders that occur due to the remote effects of tumors. Antibodies associated with these conditions may be present in the serum or cerebrospinal fluid (CSF) and can serve as useful markers of disease. […] ARUPs serum and CSF paraneoplastic reflexive panels can be used to aid in the diagnosis of paraneoplastic neurologic syndromes. Testing for the presence of antineural antibodies in both serum and CSF is recommended in most situations. […] Results must be interpreted in the clinical context of the individual patient; test results (positive or negative) should not supersede clinical judgment. […] May support a diagnosis of a paraneoplastic neurologic syndrome. […] The diagnosis of a paraneoplastic neurologic syndrome is not excluded.

• #42 Paraneoplastic neurological syndromes: a practical approach to diagnosis and management | Practical Neurology

  https://pn.bmj.com/content/22/1/19

  The intermediate-risk groups show recognised, but less reliable, clinical-serological associations. […] Overall, to maximise sensitivity and specificity, we recommend sending both serum and CSF for antibody testing as both biosamples show differing diagnostic characteristics across CNS autoimmune illnesses and, in combination, provide optimised diagnostic accuracy. […] Therefore, expert consensus suggests that a positive onconeuronal result by commercial kits should be reinforced by a second method, and that both positive and negative results are interpreted in the context of the patient presentation. […] Overall, the early recognition of a paraneoplastic cause is essential to guide oncological investigation and optimise tumour management, which is also a cornerstone in addressing the associated PNS. […] Tumour identification and appropriate oncological management are key to medical and neurological stabilisation, especially as many PNS associated with cancers display a limited immunotherapy response.

• #43 Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome | Mahta | World Journal of Oncology

  https://wjon.org/index.php/wjon/article/view/571/407

  The first step in diagnosis of PNS is to rule out other etiologies including infections, connective tissue disorders, metabolic causes or even drug side effects. If the initial work up is inconclusive, the next step would be looking for malignancy based on history, physical exam and paraclinic findings. If there is an evidence of cancer and the neurological syndrome is typical, the diagnosis is highly suggestive of PNS and further testing for onconeuronal antibodies can be helpful but is not necessary. […] Chemotherapy plus an immunosuppressive therapy and/or plasmapheresis should be initiated as soon as the diagnosis is established, however; the neurologic symptoms may or may not improve after treatment.

• #44 Paraneoplastic Neurological Syndromes: Diagnosis and Treatment Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/paraneoplastic-neurological-syndromes-diagnosis-and-treatment-strategies/

  Paraneoplastic neurological syndromes (PNS) are rare in neurology, but they pack a punch with diverse clinical presentations and dysautonomia linked to the tumor. […] Understanding PNS in neurology is crucial for early detection and treatment, which can improve outcomes for patients with brain conditions through immunotherapy. […] Identifying paraneoplastic neurological syndromes (PNS) early in neurology patients with brain tumours can significantly improve patient outcomes. […] Use comprehensive diagnostic guidelines and clues, including antibody testing, to accurately identify PNS and differentiate them from other neurological disorders in neurology, considering autoantibodies and syndrome involvement. […] Diagnosing PNS involves several steps: Identifying underlying cancer through imaging studies. Detecting specific antibodies in blood or spinal fluid. Conducting nerve conduction studies and MRI scans.

• #45 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  Paraneoplastic neurological syndromes (PNS) include any symptomatic and non-metastatic neurological manifestations associated with a neoplasm. […] Clinicians should have a high index of suspicion with acute/subacute encephalopathies to achieve a prompt diagnosis and treatment. […] Standardized diagnostic criteria and disease biomarkers are fundamental to quickly recognize PNS to allow prompt treatment initiation, thus improving the long-term outcome of these conditions. […] The traditional classification of PNS and related antibodies has been recently revised by a panel of experts which developed a new set of diagnostic criteria with the aim of improving the clinical management of these conditions. […] The clinical diagnosis of PNS requires the exclusion of other, more frequent causes, namely infectious and non-neoplastic-induced autoimmune disorders, cancers (including focal lesions as well as carcinomatous meningitis), rapidly progressive neurodegenerative disorders (e.g., prion disease, dementias, and motor neuron diseases which may present similarly to anti-Ma2-associated syndromes), and toxic/metabolic conditions.

• #46 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  The presence of encephalopathic features associated with cognitive fluctuations (even within the same day) is another clue suggesting a possible autoimmune/paraneoplastic process. […] The diagnostic certainty of PNS ranges from possible, to probable, to definite, according to the 10-point “PNS-Care Score.” […] Once diagnosed, the primary management for PNS is treatment of the underlying cancer. However, first line acute immunotherapy is frequently steroids, IVIg, or plasma exchange. […] In seronegative cases meeting criteria for PNS, empiric treatment may be considered given the clinical implications.

• #47 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  The presence of encephalopathic features associated with cognitive fluctuations (even within the same day) is another clue suggesting a possible autoimmune/paraneoplastic process. […] The diagnostic certainty of PNS ranges from possible, to probable, to definite, according to the 10-point “PNS-Care Score.” […] Once diagnosed, the primary management for PNS is treatment of the underlying cancer. However, first line acute immunotherapy is frequently steroids, IVIg, or plasma exchange. […] In seronegative cases meeting criteria for PNS, empiric treatment may be considered given the clinical implications.

• #48 Paraneoplastic Syndromes Workup: Approach Considerations, Blood Studies, Imaging Studies

  https://emedicine.medscape.com/article/280744-workup

  The update includes a new clinical scoring system for diagnosis of paraneoplastic neurologic syndrome, the Paraneoplastic (PNS)-Care Score. The PNS-Care Score assesses three factors: Phenotype classification, Associated antibody level, Presence of cancer. […] Many patients with paraneoplastic disorders may have autoantibodies against several tissues of the body. Demonstration of these autoantibodies is very important to confirm the diagnosis of a paraneoplastic syndrome and distinguish it from nonneoplastic forms. […] Any possible imaging study may be useful to detect the primary tumor in patients with paraneoplastic disorders.

• #49 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  The presence of encephalopathic features associated with cognitive fluctuations (even within the same day) is another clue suggesting a possible autoimmune/paraneoplastic process. […] The diagnostic certainty of PNS ranges from possible, to probable, to definite, according to the 10-point “PNS-Care Score.” […] Once diagnosed, the primary management for PNS is treatment of the underlying cancer. However, first line acute immunotherapy is frequently steroids, IVIg, or plasma exchange. […] In seronegative cases meeting criteria for PNS, empiric treatment may be considered given the clinical implications.

• #50 Paraneoplastic Neurologic Syndromes . | Oncohema Key

  https://oncohemakey.com/paraneoplastic-neurologic-syndromes-3/

  Therefore, early recognition and treatment of a paraneoplastic neurologic disorder along with treatment of the underlying cancer are critical to reduce neurologic morbidity and to improve overall patient survival. […] As most syndromes and malignancies are associated with more than one specific antibody, screening for a panel of paraneoplastic antibodies may increase the yield to establish a diagnosis (7, 8). […] In patients with CNS manifestation, antibody screening in CSF is usually recommended, as antibody titers in CSF are generally higher than in serum (9). […] In cases in which no underlying tumor can be identified but a high clinical suspicion for a classic paranepolastic syndrome exists, or in patients tested positive for paraneoplastic antibodies in the setting of a less classic form of a paraneoplastic neurologic syndrome, repeat cancer screening studies are recommended every 6 months (7). […] An underlying malignancy usually can be identified within the first 4 years from onset of neurological symptoms (7).

• #51 Paraneoplastic Neurologic Syndromes . | Oncohema Key

  https://oncohemakey.com/paraneoplastic-neurologic-syndromes-3/

  Therefore, early recognition and treatment of a paraneoplastic neurologic disorder along with treatment of the underlying cancer are critical to reduce neurologic morbidity and to improve overall patient survival. […] As most syndromes and malignancies are associated with more than one specific antibody, screening for a panel of paraneoplastic antibodies may increase the yield to establish a diagnosis (7, 8). […] In patients with CNS manifestation, antibody screening in CSF is usually recommended, as antibody titers in CSF are generally higher than in serum (9). […] In cases in which no underlying tumor can be identified but a high clinical suspicion for a classic paranepolastic syndrome exists, or in patients tested positive for paraneoplastic antibodies in the setting of a less classic form of a paraneoplastic neurologic syndrome, repeat cancer screening studies are recommended every 6 months (7). […] An underlying malignancy usually can be identified within the first 4 years from onset of neurological symptoms (7).

• #52 Paraneoplastic Neurological Syndromes: Laboratory Support of Diagnosis | Clinical Focus | Quest Diagnostics HER2 (ERBB2; HER-2/neu) TestingHER2 (ERBB2; HER-2/neu) Testing

  https://testdirectory.questdiagnostics.com/test/test-guides/CF_Paraneoplastic_Syndromes/paraneoplastic-neurological-syndromes-laboratory-support-of-diagnosis?p=r

  This Clinical Focus discusses the role of autoantibody testing in the diagnosis of paraneoplastic neurological syndromes and associated cancer and tumor types. […] Paraneoplastic neurological syndromes (PNSs) occur when cancer triggers an immune response that attacks the nervous system. Symptoms vary based on the part of the nervous system that is attacked and can include cognitive, psychiatric, autonomic, and sensorimotor effects. […] Diagnosis can be complicated because signs and symptoms of the different syndromes overlap. In addition, autoimmune neurological syndromes are not always paraneoplastic (ie, caused by cancer); they can be caused by infectious agents, toxins, or metabolic conditions. The diagnosis of a PNS and identification of an underlying malignancy can involve imaging and laboratory tests.

• #53 Paraneoplastic Syndrome: Causes, Symptoms, Treatment, and Outlook

  https://resources.healthgrades.com/right-care/brain-and-nerves/paraneoplastic-syndrome

  Paraneoplastic syndromes are a group of disorders that affect the nervous systems of people with cancerous tumors called “neoplasms.” Symptoms result from the immune system’s reaction to cancer and vary depending on which part of the nervous system is affected. […] This article talks about the different types of PNS and their symptoms, diagnosis, treatments, and outlook. […] Diagnosing PNS can be difficult because the symptoms can look similar to other conditions. In most cases, the people experiencing symptoms are unaware of the tumor causing it. […] Doctors typically use blood tests, imaging tests, and biopsies to diagnose PNS. Treatment focuses on addressing cancer, reducing the immune system response, and starting speech and physical therapies. The outlook for someone with PNS typically depends on the stage of cancer.

• #54 Paraneoplastic Neurological Disorders | PM&R KnowledgeNow

  https://now.aapmr.org/neuromuscular-manifestations-of-neoplasms-and-paraneoplastic-syndromes/

  Paraneoplastic neurological syndromes (PNS) are a group of neurological disorders resulting from an immune response triggered by an underlying tumor that affects the central and/or peripheral nervous systems, directed originally against the tumor itself. […] Patients with suspected PNS should obtain both serum and CSF antibody screening. Antibodies against intracellular antigens are almost always detectable in serum. Antibodies against cell-surface or synaptic proteins may be absent in serum testing and are typically found in higher titers in CSF than serum. […] Early diagnosis is critical as delays in care can lead to permanent neurological deficits, although literature evaluating early prognostic factors is limited. […] PNS is difficult to diagnose but early diagnosis and initiation of treatment is critical to prevent permanent neurological deficits. Symptoms of PNS may include ataxia, encephalitis, peripheral neuropathy, memory problems, seizures, sensory motor neuropathies, anorexia, rapid weight loss and fatigue. […] The different subtypes of PNS are defined by the presence or the absence of paraneoplastic antibodies and the type of antibodies. Management and treatment should be tailored to each subtype. […] Coordination between the physiatrist, therapist, oncologist, and neurologist are paramount.

• #55 Paraneoplastic syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Paraneoplastic_syndrome

  A paraneoplastic syndrome is a syndrome (a set of signs and symptoms) that is the consequence of a tumor in the body (usually a cancerous one). It is specifically due to the production of chemical signaling molecules (such as hormones or cytokines) by tumor cells or by an immune response against the tumor. […] Diagnosis may be difficult in patients in whom paraneoplastic antibodies cannot be detected. In the absence of these antibodies, other tests that may be helpful include MRI, PET, lumbar puncture and electrophysiology. […] A specifically devastating form of (neurological) paraneoplastic syndromes is a group of disorders classified as paraneoplastic neurological disorders (PNDs). These PNDs affect the central or peripheral nervous system; some are degenerative, though others (such as LEMS) may improve with treatment of the condition or the tumor.

• #56 Paraneoplastic Syndromes Workup: Approach Considerations, Blood Studies, Imaging Studies

  https://emedicine.medscape.com/article/280744-workup

  Patients with a suspected paraneoplastic disorder should undergo a complete panel of laboratory studies of blood, urine, and cerebrospinal fluid (CSF). Selection of further studies is dictated by the clinical presentation. […] Assays for autoantibodies may confirm the paraneoplastic origin of a patients condition. Most autoantibodies involved in paraneoplastic syndromes are directed against nervous system structures. […] In 2021, an international panel of experts published an update to the 2004 criteria for the diagnosis of paraneoplastic neurologic syndromes. Under the updated criteria, neurologic phenotypes are classified as high risk or intermediate risk for cancer, and associated antibodies are classified as high risk (cancer in 70% of patients with the antibody), intermediate risk (cancer in 30%-70%), and low risk (cancer in 30%).

• #57 Imaging Review of Paraneoplastic Neurologic Syndromes | American Journal of Neuroradiology

  http://www.ajnr.org/content/early/2020/10/22/ajnr.A6815

  The treatment for paraneoplastic cranial neuropathy is not well studied and mainly involves management of the underlying malignancy. […] The diagnostic work-up should include a thorough history to elicit any antecedent infection that may suggest Guillain-Barr syndrome, a complete neurologic examination, paraneoplastic antibody testing, electromyography, and lumbar spine MR imaging. […] Typical treatment includes management of the underlying malignancy and immunosuppression.

• #58 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Most PNDs develop and progress rapidly until stabilization in a few weeks or months, causing severe disability. […] All patients with PNDs of the CNS and some peripheral nerve syndromes (e.g., plexopathies) should undergo neuroimaging evaluation of the involved area. […] In most PNDs of the CNS, the function of the blood-brain barrier is preserved, and therefore the affected brain regions are rarely enhanced with contrast material. […] Detection of CSF antibodies is a strong indicator that the associated neurological syndrome is paraneoplastic. […] Close oncological surveillance should be undertaken in patients with classical PNDs with or without paraneoplastic antibodies and in patients with nonclassical PND and paraneoplastic antibodies. […] Paraneoplastic antibodies are antibodies whose presence serves as a marker of the paraneoplastic origin of a neurological syndrome. […] Detection of any of these antibodies strongly supports the diagnosis of PND even if no tumor is found at initial evaluation.

• #59 Paraneoplastic Syndromes Workup: Approach Considerations, Blood Studies, Imaging Studies

  https://emedicine.medscape.com/article/280744-workup

  Patients with a suspected paraneoplastic disorder should undergo a complete panel of laboratory studies of blood, urine, and cerebrospinal fluid (CSF). Selection of further studies is dictated by the clinical presentation. […] Assays for autoantibodies may confirm the paraneoplastic origin of a patients condition. Most autoantibodies involved in paraneoplastic syndromes are directed against nervous system structures. […] In 2021, an international panel of experts published an update to the 2004 criteria for the diagnosis of paraneoplastic neurologic syndromes. Under the updated criteria, neurologic phenotypes are classified as high risk or intermediate risk for cancer, and associated antibodies are classified as high risk (cancer in 70% of patients with the antibody), intermediate risk (cancer in 30%-70%), and low risk (cancer in 30%).

• #60 Paraneoplastic Neurological Disorders | PM&R KnowledgeNow

  https://now.aapmr.org/neuromuscular-manifestations-of-neoplasms-and-paraneoplastic-syndromes/

  Paraneoplastic neurological syndromes (PNS) are a group of neurological disorders resulting from an immune response triggered by an underlying tumor that affects the central and/or peripheral nervous systems, directed originally against the tumor itself. […] Patients with suspected PNS should obtain both serum and CSF antibody screening. Antibodies against intracellular antigens are almost always detectable in serum. Antibodies against cell-surface or synaptic proteins may be absent in serum testing and are typically found in higher titers in CSF than serum. […] Early diagnosis is critical as delays in care can lead to permanent neurological deficits, although literature evaluating early prognostic factors is limited. […] PNS is difficult to diagnose but early diagnosis and initiation of treatment is critical to prevent permanent neurological deficits. Symptoms of PNS may include ataxia, encephalitis, peripheral neuropathy, memory problems, seizures, sensory motor neuropathies, anorexia, rapid weight loss and fatigue. […] The different subtypes of PNS are defined by the presence or the absence of paraneoplastic antibodies and the type of antibodies. Management and treatment should be tailored to each subtype. […] Coordination between the physiatrist, therapist, oncologist, and neurologist are paramount.

• #61

  https://ama.ba/index.php/ama/article/view/574

  Paraneoplastic syndromes are related to the presence of a malignancy and are not secondary to treatment. […] Diagnosis follows specific criteria, and they are caused by tumor-directed antibodies known as onconeural antibodies. […] A multidisciplinary team is needed for potentially earlier diagnosis and PNS improvement, better prognosis, and increased overall survival and quality of life.

• #62 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Most PNDs develop and progress rapidly until stabilization in a few weeks or months, causing severe disability. […] All patients with PNDs of the CNS and some peripheral nerve syndromes (e.g., plexopathies) should undergo neuroimaging evaluation of the involved area. […] In most PNDs of the CNS, the function of the blood-brain barrier is preserved, and therefore the affected brain regions are rarely enhanced with contrast material. […] Detection of CSF antibodies is a strong indicator that the associated neurological syndrome is paraneoplastic. […] Close oncological surveillance should be undertaken in patients with classical PNDs with or without paraneoplastic antibodies and in patients with nonclassical PND and paraneoplastic antibodies. […] Paraneoplastic antibodies are antibodies whose presence serves as a marker of the paraneoplastic origin of a neurological syndrome. […] Detection of any of these antibodies strongly supports the diagnosis of PND even if no tumor is found at initial evaluation.

• #63 Paraneoplastic syndromes of the nervous system // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/paraneoplastic-syndromes-of-the-nervous-system

  Paraneoplastic syndromes of the nervous system are a group of rare conditions that develop in some people who have cancer. […] Paraneoplastic syndromes of the nervous system occur when cancer-fighting agents of the immune system also attack parts of the brain, spinal cord, peripheral nerves or muscle. […] Symptoms of paraneoplastic syndromes of the nervous system can develop relatively quickly, often over days to weeks. […] But if you have any symptoms suggesting a paraneoplastic syndrome, see your healthcare professional as soon as possible. Early diagnosis and appropriate care are important for treating the cancer and preventing further damage of the nervous system. […] To diagnose paraneoplastic syndrome of the nervous system, you may need a physical exam and blood tests. You also may need imaging tests or a spinal tap, also known as a lumbar puncture.

• #64 Paraneoplastic Neurological Syndromes: Diagnosis and Treatment Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/paraneoplastic-neurological-syndromes-diagnosis-and-treatment-strategies/

  Treatment focuses on managing both the cancer and paraneoplastic neurological symptoms in patients with a tumour. […] Early recognition of PNS is essential for effective treatment. Identifying these syndromes quickly allows doctors to start appropriate therapies sooner, according to a pubmed article found on google. […] Paraneoplastic neurological syndromes (PNS) can be challenging to diagnose. Early symptoms often appear before any detectable cancer. This makes early diagnosis crucial. Diagnostic criteria include a combination of clinical assessment and laboratory findings, as noted in the article on PubMed. […] Onconeural antibodies play a significant role in diagnosing PNS. These antibodies target proteins in neurons and are found in the blood of patients with PNS, as noted in a PubMed article found via Google. Seropositive cases indicate the presence of these antibodies, which helps confirm the diagnosis, as reported in the article on PubMed and Google. […] Detecting an underlying malignancy is crucial in managing PNS. Onconeural antibodies guide doctors to look for specific cancers, such as lung or breast cancer, pubmed, google. Early detection of cancer improves treatment outcomes significantly.

• #65 Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes

  https://www.mdpi.com/2073-4468/12/3/50?type=check_update&version=1

  The first and most important goal of treating PNSs is identifying and treating the underlying malignancy. […] For PNSs mediated by antibodies directed against synaptic or cell membrane proteins (i.e., the antibodies themselves are directly pathogenic), antibody-depleting and immunosuppressive therapy can be quite effective. […] Unfortunately, PNSs caused by antibodies directed against intracellular antigens and mediated by T cells tend to be poorly responsive to treatment. […] Prognosis can vary depending on the specific PNS and the underlying pathophysiology. […] The exact pathophysiologic relationship of PNS and their associated onconeural antibodies varies depending on the specific syndrome and underlying malignancy. […] Immune suppression remains the mainstay of PNS treatment, but more prospective studies are needed to evaluate the efficacy of various immunotherapeutic approaches.

• #66 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  The presence of encephalopathic features associated with cognitive fluctuations (even within the same day) is another clue suggesting a possible autoimmune/paraneoplastic process. […] The diagnostic certainty of PNS ranges from possible, to probable, to definite, according to the 10-point “PNS-Care Score.” […] Once diagnosed, the primary management for PNS is treatment of the underlying cancer. However, first line acute immunotherapy is frequently steroids, IVIg, or plasma exchange. […] In seronegative cases meeting criteria for PNS, empiric treatment may be considered given the clinical implications.

• #67 PARANEOPLASTIC DISORDERS OF THE NERVOUS SYSTEM | Neupsy Key

  https://neupsykey.com/paraneoplastic-disorders-of-the-nervous-system/

  Paraneoplastic neurological disorders (PNDs) are an extensive group of syndromes that can affect any part of the nervous system by mechanisms that are mostly immune mediated. […] In 60% of patients with PND, symptoms develop before the presence of a tumor is known; the majority of these patients are seen by neurologists, who should be aware that prompt diagnosis and treatment of the tumor along with immunotherapy may stabilize or improve the PND. […] The diagnosis of PND has been facilitated by serological tests that are based on the detection of antineuronal antibodies in the patients serum or cerebrospinal fluid (CSF), but in at least 40% of patients, no antibodies are detected, and in some instances, the antibodies can be detected in patients who have cancer but not PND. […] The diagnosis of PNDs is usually based on (1) the recognition of the neurological syndrome, (2) the demonstration of the associated cancer, and (3) the detection of serum and CSF paraneoplastic antibodies.

• #68 Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment

  https://www.mdpi.com/2227-9059/11/5/1406

  Paraneoplastic neurological syndromes (PNS) include any symptomatic and non-metastatic neurological manifestations associated with a neoplasm. […] Clinicians should have a high index of suspicion with acute/subacute encephalopathies to achieve a prompt diagnosis and treatment. […] Standardized diagnostic criteria and disease biomarkers are fundamental to quickly recognize PNS to allow prompt treatment initiation, thus improving the long-term outcome of these conditions. […] The traditional classification of PNS and related antibodies has been recently revised by a panel of experts which developed a new set of diagnostic criteria with the aim of improving the clinical management of these conditions. […] The clinical diagnosis of PNS requires the exclusion of other, more frequent causes, namely infectious and non-neoplastic-induced autoimmune disorders, cancers (including focal lesions as well as carcinomatous meningitis), rapidly progressive neurodegenerative disorders (e.g., prion disease, dementias, and motor neuron diseases which may present similarly to anti-Ma2-associated syndromes), and toxic/metabolic conditions.

• #69 Paraneoplastic Syndromes: Symptoms, Types & Treatment

  https://my.clevelandclinic.org/health/diseases/17938-paraneoplastic-syndromes

  Paraneoplastic syndromes affecting your central nervous system (brain, spinal cord) and your peripheral nervous system (nerves outside of your brain and spinal cord) may cause: […] Your healthcare provider will diagnose paraneoplastic syndromes with a medical history, physical exam and several tests. […] Paraneoplastic syndromes often affect your nervous system, impacting your brain and muscle function. Your provider may ask you to perform specific tasks to check how your nervous system functions. […] Your healthcare provider will treat the underlying cancer thats causing your symptoms. Theyll also work to manage your symptoms to decrease any damage to your bodys organs or systems. […] Cancerous tumors cause unexpected changes in your body, including (sometimes) the symptoms of a paraneoplastic syndrome. There are multiple syndromes, and the symptoms are varied. As a result, it may take time for your healthcare provider to recognize your symptoms as cancer-related. Once they confirm your diagnosis, they can recommend treatments to address your symptoms and, most importantly, treat the underlying tumor causing the problem. Receiving the most effective cancer treatments provides the best outlook for managing a paraneoplastic syndrome.

• #70 Paraneoplastic neurological syndromes: a practical approach to diagnosis and management | Practical Neurology

  https://pn.bmj.com/content/22/1/19

  The intermediate-risk groups show recognised, but less reliable, clinical-serological associations. […] Overall, to maximise sensitivity and specificity, we recommend sending both serum and CSF for antibody testing as both biosamples show differing diagnostic characteristics across CNS autoimmune illnesses and, in combination, provide optimised diagnostic accuracy. […] Therefore, expert consensus suggests that a positive onconeuronal result by commercial kits should be reinforced by a second method, and that both positive and negative results are interpreted in the context of the patient presentation. […] Overall, the early recognition of a paraneoplastic cause is essential to guide oncological investigation and optimise tumour management, which is also a cornerstone in addressing the associated PNS. […] Tumour identification and appropriate oncological management are key to medical and neurological stabilisation, especially as many PNS associated with cancers display a limited immunotherapy response.

• #71 Paraneoplastic neurological syndromes | PPT

  https://www.slideshare.net/slideshow/paraneoplastic-neurological-syndromes/30608508

  Autoantibodies Presence of autoantibodies: helps to confirm the clinical diagnosis focus the search for an underlying malignancy Anti-Hu, Anti-Yo, Anti-Ri, Anti-Tr, Anti-CV2, etc. […] Treatment two treatment approaches removal of the source of the antigen by treatment of the underlying tumor, and, suppression of the immune response Overall results disappointing in majority. […] Many reports suggest that patients with paraneoplastic neurologic disorders have a better prognosis than patients with histologically identical tumors that are not associated with paraneoplastic neurologic disorders. […] Paraneoplastic syndromes are generally, but not always, irreversible Neurologic disability caused by paraneoplastic syndromes is often profound in the absence of any other cancer symptoms. […] Paraneoplastic syndromes may affect any portion of the nervous system Cerebral cortex Brainstem Spinal cord Peripheral nerves Neuromuscular junction Muscle. […] The tumor is often occult, and the neurologic disorder typically precedes the diagnosis of the tumor. […] The histologic features of tumors in paraneoplastic neurologic disorders do not differ from those of other tumors, except that the tumors may be heavily infiltrated with inflammatory cells.

• #72 Paraneoplastic neurological syndromes | PPT

  https://www.slideshare.net/slideshow/paraneoplastic-neurological-syndromes/30608508

  Autoantibodies Presence of autoantibodies: helps to confirm the clinical diagnosis focus the search for an underlying malignancy Anti-Hu, Anti-Yo, Anti-Ri, Anti-Tr, Anti-CV2, etc. […] Treatment two treatment approaches removal of the source of the antigen by treatment of the underlying tumor, and, suppression of the immune response Overall results disappointing in majority. […] Many reports suggest that patients with paraneoplastic neurologic disorders have a better prognosis than patients with histologically identical tumors that are not associated with paraneoplastic neurologic disorders. […] Paraneoplastic syndromes are generally, but not always, irreversible Neurologic disability caused by paraneoplastic syndromes is often profound in the absence of any other cancer symptoms. […] Paraneoplastic syndromes may affect any portion of the nervous system Cerebral cortex Brainstem Spinal cord Peripheral nerves Neuromuscular junction Muscle. […] The tumor is often occult, and the neurologic disorder typically precedes the diagnosis of the tumor. […] The histologic features of tumors in paraneoplastic neurologic disorders do not differ from those of other tumors, except that the tumors may be heavily infiltrated with inflammatory cells.

Zobacz więcej